Loading…
Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB
Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signali...
Saved in:
Published in: | Nature communications 2025-01, Vol.16 (1), p.496-18, Article 496 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c422t-59e011013b9c143147216ce586462d0cb12de8d9d4cf1b843bdadb840bad0bf3 |
container_end_page | 18 |
container_issue | 1 |
container_start_page | 496 |
container_title | Nature communications |
container_volume | 16 |
creator | Hou, Peili Zhu, Hongchao Chu, Fengyun Gao, Yan Sun, Xiaonan Zhang, Fuzhen Wang, Xiaomeng Feng, Yueyue Li, Xingyu Liu, Yu Wang, Jun Wang, Xiaoyun He, Daniel Chang Wang, Hongmei He, Hongbin |
description | Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signaling pathway to resist viral infection in cells and mice. Mechanistically, PBLD activates NF-κB signaling pathway during viral infection via blocking tripartite motif containing 21 (TRIM21)-mediated phosphorylated inhibitory kappa B kinase beta (IKKβ) degradation. Furthermore, we show Cedrelone inhibits viral replication by increasing the PBLD protein expression and subsequently activating NF-κB-mediated IFN-I response. Furthermore, the therapeutic potential of Cedrelone lies in its ability to enhance antiviral immunity in primary macrophages and to promote survival and reduce lung tissue damage in HSV-1-infected mice in a PBLD-dependent manner. Consequently, our findings provide a potential combination model that targets PBLD for Cedrelone antiviral drug therapy, potentially paving the way for the development of broad-spectrum antiviral agents.
Phenazine biosynthesis-like domain-containing protein (PBLD) and cedrelone play roles in tumor suppression. Here, authors suggest that PBLD and Cedrelone inhibit viral replication via activating the NF-κB-mediated IFN-I signaling response in cells and mice. |
doi_str_mv | 10.1038/s41467-024-54882-y |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_3bfbd6c408b749bfa92e6e7f71512fb9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_3bfbd6c408b749bfa92e6e7f71512fb9</doaj_id><sourcerecordid>3152797469</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-59e011013b9c143147216ce586462d0cb12de8d9d4cf1b843bdadb840bad0bf3</originalsourceid><addsrcrecordid>eNp9ks1uEzEUhUcIRKvSF2CBRmJTFgO-tjMerxANFCpF0EX3ln_uJC4zdrAnlcKOt-IBeDCcppSWBd5cy-f4873WqarnQF4DYd2bzIG3oiGUNzPedbTZPqoOKeHQgKDs8b39QXWc8xUpi0noOH9aHTAphGw7dlj9uFhh0N99wNr4mLdhWmH2uRn8V6xdHLUPjY1hKtWHZb1OcUIf6pOL08X7V7UOrp6jSzjEAijiWORyOvlrn_RQ-3HcFCFhXseQyxPbWtsi6mkH-3zW_Pp5-qx60ush4_FtPaouzz5czj81iy8fz-fvFo3llE7NTCIBIMCMtMAZcEGhtTjrWt5SR6wB6rBz0nHbg-k4M067UonRjpieHVXne6yL-kqtkx912qqovbo5iGmpdJq8HVAx0xvXWk46I7g0vZYUWxS9gBnQ3sjCertnrTdmRGcxTGXaB9CHSvArtYzXCkAAcMIK4eSWkOK3DeZJjT5bHAYdMG6yYtASSUkn2mJ9-Y_1Km5SKF9VXDMqpODtriW6d9kUc07Y33UDRO0Co_aBUSUw6iYwalsuvbg_x92VP_EoBrY35CKFJaa_b_8H-xudBc8c</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3152797469</pqid></control><display><type>article</type><title>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB</title><source>Nature</source><source>Publicly Available Content (ProQuest)</source><source>PubMed Central</source><source>Coronavirus Research Database</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Hou, Peili ; Zhu, Hongchao ; Chu, Fengyun ; Gao, Yan ; Sun, Xiaonan ; Zhang, Fuzhen ; Wang, Xiaomeng ; Feng, Yueyue ; Li, Xingyu ; Liu, Yu ; Wang, Jun ; Wang, Xiaoyun ; He, Daniel Chang ; Wang, Hongmei ; He, Hongbin</creator><creatorcontrib>Hou, Peili ; Zhu, Hongchao ; Chu, Fengyun ; Gao, Yan ; Sun, Xiaonan ; Zhang, Fuzhen ; Wang, Xiaomeng ; Feng, Yueyue ; Li, Xingyu ; Liu, Yu ; Wang, Jun ; Wang, Xiaoyun ; He, Daniel Chang ; Wang, Hongmei ; He, Hongbin</creatorcontrib><description>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signaling pathway to resist viral infection in cells and mice. Mechanistically, PBLD activates NF-κB signaling pathway during viral infection via blocking tripartite motif containing 21 (TRIM21)-mediated phosphorylated inhibitory kappa B kinase beta (IKKβ) degradation. Furthermore, we show Cedrelone inhibits viral replication by increasing the PBLD protein expression and subsequently activating NF-κB-mediated IFN-I response. Furthermore, the therapeutic potential of Cedrelone lies in its ability to enhance antiviral immunity in primary macrophages and to promote survival and reduce lung tissue damage in HSV-1-infected mice in a PBLD-dependent manner. Consequently, our findings provide a potential combination model that targets PBLD for Cedrelone antiviral drug therapy, potentially paving the way for the development of broad-spectrum antiviral agents.
Phenazine biosynthesis-like domain-containing protein (PBLD) and cedrelone play roles in tumor suppression. Here, authors suggest that PBLD and Cedrelone inhibit viral replication via activating the NF-κB-mediated IFN-I signaling response in cells and mice.</description><identifier>ISSN: 2041-1723</identifier><identifier>EISSN: 2041-1723</identifier><identifier>DOI: 10.1038/s41467-024-54882-y</identifier><identifier>PMID: 39779683</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/1 ; 13/109 ; 13/31 ; 13/95 ; 14/19 ; 38 ; 42 ; 45 ; 49 ; 59 ; 631/250/2504/342 ; 631/250/255/2514 ; 631/250/262 ; 631/326/596/2553 ; 64 ; 64/86 ; 96 ; Animals ; Antiviral agents ; Antiviral Agents - pharmacology ; Antiviral drugs ; Biosynthesis ; Cell survival ; Chemotherapy ; Cyclohexanones - pharmacology ; Drug therapy ; Female ; HEK293 Cells ; Herpes Simplex - drug therapy ; Herpes Simplex - immunology ; Herpes Simplex - virology ; Herpesvirus 1, Human - drug effects ; Herpesvirus 1, Human - immunology ; Humanities and Social Sciences ; Humans ; I-kappa B Kinase - metabolism ; Immune response ; Immune system ; Infections ; Interferon ; Interferon Type I - immunology ; Interferon Type I - metabolism ; Intracellular Signaling Peptides and Proteins ; Kinases ; Macrophages ; Macrophages - drug effects ; Macrophages - immunology ; Macrophages - metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; multidisciplinary ; NF-kappa B - metabolism ; NF-κB protein ; Phenazine ; Phenazines - pharmacology ; Protein biosynthesis ; Proteins ; Replication ; Science ; Science (multidisciplinary) ; Signal transduction ; Signal Transduction - drug effects ; Suppressors ; Tumor suppression ; Tumors ; Viral infections ; Virus Replication - drug effects</subject><ispartof>Nature communications, 2025-01, Vol.16 (1), p.496-18, Article 496</ispartof><rights>The Author(s) 2025</rights><rights>2025. The Author(s).</rights><rights>Copyright Nature Publishing Group 2025</rights><rights>The Author(s) 2025 2025</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c422t-59e011013b9c143147216ce586462d0cb12de8d9d4cf1b843bdadb840bad0bf3</cites><orcidid>0000-0002-7438-0638 ; 0009-0003-1629-1172</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3152797469/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3152797469?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,38493,43871,44566,53766,53768,74155,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39779683$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hou, Peili</creatorcontrib><creatorcontrib>Zhu, Hongchao</creatorcontrib><creatorcontrib>Chu, Fengyun</creatorcontrib><creatorcontrib>Gao, Yan</creatorcontrib><creatorcontrib>Sun, Xiaonan</creatorcontrib><creatorcontrib>Zhang, Fuzhen</creatorcontrib><creatorcontrib>Wang, Xiaomeng</creatorcontrib><creatorcontrib>Feng, Yueyue</creatorcontrib><creatorcontrib>Li, Xingyu</creatorcontrib><creatorcontrib>Liu, Yu</creatorcontrib><creatorcontrib>Wang, Jun</creatorcontrib><creatorcontrib>Wang, Xiaoyun</creatorcontrib><creatorcontrib>He, Daniel Chang</creatorcontrib><creatorcontrib>Wang, Hongmei</creatorcontrib><creatorcontrib>He, Hongbin</creatorcontrib><title>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB</title><title>Nature communications</title><addtitle>Nat Commun</addtitle><addtitle>Nat Commun</addtitle><description>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signaling pathway to resist viral infection in cells and mice. Mechanistically, PBLD activates NF-κB signaling pathway during viral infection via blocking tripartite motif containing 21 (TRIM21)-mediated phosphorylated inhibitory kappa B kinase beta (IKKβ) degradation. Furthermore, we show Cedrelone inhibits viral replication by increasing the PBLD protein expression and subsequently activating NF-κB-mediated IFN-I response. Furthermore, the therapeutic potential of Cedrelone lies in its ability to enhance antiviral immunity in primary macrophages and to promote survival and reduce lung tissue damage in HSV-1-infected mice in a PBLD-dependent manner. Consequently, our findings provide a potential combination model that targets PBLD for Cedrelone antiviral drug therapy, potentially paving the way for the development of broad-spectrum antiviral agents.
Phenazine biosynthesis-like domain-containing protein (PBLD) and cedrelone play roles in tumor suppression. Here, authors suggest that PBLD and Cedrelone inhibit viral replication via activating the NF-κB-mediated IFN-I signaling response in cells and mice.</description><subject>13/1</subject><subject>13/109</subject><subject>13/31</subject><subject>13/95</subject><subject>14/19</subject><subject>38</subject><subject>42</subject><subject>45</subject><subject>49</subject><subject>59</subject><subject>631/250/2504/342</subject><subject>631/250/255/2514</subject><subject>631/250/262</subject><subject>631/326/596/2553</subject><subject>64</subject><subject>64/86</subject><subject>96</subject><subject>Animals</subject><subject>Antiviral agents</subject><subject>Antiviral Agents - pharmacology</subject><subject>Antiviral drugs</subject><subject>Biosynthesis</subject><subject>Cell survival</subject><subject>Chemotherapy</subject><subject>Cyclohexanones - pharmacology</subject><subject>Drug therapy</subject><subject>Female</subject><subject>HEK293 Cells</subject><subject>Herpes Simplex - drug therapy</subject><subject>Herpes Simplex - immunology</subject><subject>Herpes Simplex - virology</subject><subject>Herpesvirus 1, Human - drug effects</subject><subject>Herpesvirus 1, Human - immunology</subject><subject>Humanities and Social Sciences</subject><subject>Humans</subject><subject>I-kappa B Kinase - metabolism</subject><subject>Immune response</subject><subject>Immune system</subject><subject>Infections</subject><subject>Interferon</subject><subject>Interferon Type I - immunology</subject><subject>Interferon Type I - metabolism</subject><subject>Intracellular Signaling Peptides and Proteins</subject><subject>Kinases</subject><subject>Macrophages</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - immunology</subject><subject>Macrophages - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>multidisciplinary</subject><subject>NF-kappa B - metabolism</subject><subject>NF-κB protein</subject><subject>Phenazine</subject><subject>Phenazines - pharmacology</subject><subject>Protein biosynthesis</subject><subject>Proteins</subject><subject>Replication</subject><subject>Science</subject><subject>Science (multidisciplinary)</subject><subject>Signal transduction</subject><subject>Signal Transduction - drug effects</subject><subject>Suppressors</subject><subject>Tumor suppression</subject><subject>Tumors</subject><subject>Viral infections</subject><subject>Virus Replication - drug effects</subject><issn>2041-1723</issn><issn>2041-1723</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks1uEzEUhUcIRKvSF2CBRmJTFgO-tjMerxANFCpF0EX3ln_uJC4zdrAnlcKOt-IBeDCcppSWBd5cy-f4873WqarnQF4DYd2bzIG3oiGUNzPedbTZPqoOKeHQgKDs8b39QXWc8xUpi0noOH9aHTAphGw7dlj9uFhh0N99wNr4mLdhWmH2uRn8V6xdHLUPjY1hKtWHZb1OcUIf6pOL08X7V7UOrp6jSzjEAijiWORyOvlrn_RQ-3HcFCFhXseQyxPbWtsi6mkH-3zW_Pp5-qx60ush4_FtPaouzz5czj81iy8fz-fvFo3llE7NTCIBIMCMtMAZcEGhtTjrWt5SR6wB6rBz0nHbg-k4M067UonRjpieHVXne6yL-kqtkx912qqovbo5iGmpdJq8HVAx0xvXWk46I7g0vZYUWxS9gBnQ3sjCertnrTdmRGcxTGXaB9CHSvArtYzXCkAAcMIK4eSWkOK3DeZJjT5bHAYdMG6yYtASSUkn2mJ9-Y_1Km5SKF9VXDMqpODtriW6d9kUc07Y33UDRO0Co_aBUSUw6iYwalsuvbg_x92VP_EoBrY35CKFJaa_b_8H-xudBc8c</recordid><startdate>20250108</startdate><enddate>20250108</enddate><creator>Hou, Peili</creator><creator>Zhu, Hongchao</creator><creator>Chu, Fengyun</creator><creator>Gao, Yan</creator><creator>Sun, Xiaonan</creator><creator>Zhang, Fuzhen</creator><creator>Wang, Xiaomeng</creator><creator>Feng, Yueyue</creator><creator>Li, Xingyu</creator><creator>Liu, Yu</creator><creator>Wang, Jun</creator><creator>Wang, Xiaoyun</creator><creator>He, Daniel Chang</creator><creator>Wang, Hongmei</creator><creator>He, Hongbin</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7ST</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>SOI</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7438-0638</orcidid><orcidid>https://orcid.org/0009-0003-1629-1172</orcidid></search><sort><creationdate>20250108</creationdate><title>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB</title><author>Hou, Peili ; Zhu, Hongchao ; Chu, Fengyun ; Gao, Yan ; Sun, Xiaonan ; Zhang, Fuzhen ; Wang, Xiaomeng ; Feng, Yueyue ; Li, Xingyu ; Liu, Yu ; Wang, Jun ; Wang, Xiaoyun ; He, Daniel Chang ; Wang, Hongmei ; He, Hongbin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-59e011013b9c143147216ce586462d0cb12de8d9d4cf1b843bdadb840bad0bf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>13/1</topic><topic>13/109</topic><topic>13/31</topic><topic>13/95</topic><topic>14/19</topic><topic>38</topic><topic>42</topic><topic>45</topic><topic>49</topic><topic>59</topic><topic>631/250/2504/342</topic><topic>631/250/255/2514</topic><topic>631/250/262</topic><topic>631/326/596/2553</topic><topic>64</topic><topic>64/86</topic><topic>96</topic><topic>Animals</topic><topic>Antiviral agents</topic><topic>Antiviral Agents - pharmacology</topic><topic>Antiviral drugs</topic><topic>Biosynthesis</topic><topic>Cell survival</topic><topic>Chemotherapy</topic><topic>Cyclohexanones - pharmacology</topic><topic>Drug therapy</topic><topic>Female</topic><topic>HEK293 Cells</topic><topic>Herpes Simplex - drug therapy</topic><topic>Herpes Simplex - immunology</topic><topic>Herpes Simplex - virology</topic><topic>Herpesvirus 1, Human - drug effects</topic><topic>Herpesvirus 1, Human - immunology</topic><topic>Humanities and Social Sciences</topic><topic>Humans</topic><topic>I-kappa B Kinase - metabolism</topic><topic>Immune response</topic><topic>Immune system</topic><topic>Infections</topic><topic>Interferon</topic><topic>Interferon Type I - immunology</topic><topic>Interferon Type I - metabolism</topic><topic>Intracellular Signaling Peptides and Proteins</topic><topic>Kinases</topic><topic>Macrophages</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - immunology</topic><topic>Macrophages - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>multidisciplinary</topic><topic>NF-kappa B - metabolism</topic><topic>NF-κB protein</topic><topic>Phenazine</topic><topic>Phenazines - pharmacology</topic><topic>Protein biosynthesis</topic><topic>Proteins</topic><topic>Replication</topic><topic>Science</topic><topic>Science (multidisciplinary)</topic><topic>Signal transduction</topic><topic>Signal Transduction - drug effects</topic><topic>Suppressors</topic><topic>Tumor suppression</topic><topic>Tumors</topic><topic>Viral infections</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hou, Peili</creatorcontrib><creatorcontrib>Zhu, Hongchao</creatorcontrib><creatorcontrib>Chu, Fengyun</creatorcontrib><creatorcontrib>Gao, Yan</creatorcontrib><creatorcontrib>Sun, Xiaonan</creatorcontrib><creatorcontrib>Zhang, Fuzhen</creatorcontrib><creatorcontrib>Wang, Xiaomeng</creatorcontrib><creatorcontrib>Feng, Yueyue</creatorcontrib><creatorcontrib>Li, Xingyu</creatorcontrib><creatorcontrib>Liu, Yu</creatorcontrib><creatorcontrib>Wang, Jun</creatorcontrib><creatorcontrib>Wang, Xiaoyun</creatorcontrib><creatorcontrib>He, Daniel Chang</creatorcontrib><creatorcontrib>Wang, Hongmei</creatorcontrib><creatorcontrib>He, Hongbin</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Environment Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>Environment Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Nature communications</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hou, Peili</au><au>Zhu, Hongchao</au><au>Chu, Fengyun</au><au>Gao, Yan</au><au>Sun, Xiaonan</au><au>Zhang, Fuzhen</au><au>Wang, Xiaomeng</au><au>Feng, Yueyue</au><au>Li, Xingyu</au><au>Liu, Yu</au><au>Wang, Jun</au><au>Wang, Xiaoyun</au><au>He, Daniel Chang</au><au>Wang, Hongmei</au><au>He, Hongbin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB</atitle><jtitle>Nature communications</jtitle><stitle>Nat Commun</stitle><addtitle>Nat Commun</addtitle><date>2025-01-08</date><risdate>2025</risdate><volume>16</volume><issue>1</issue><spage>496</spage><epage>18</epage><pages>496-18</pages><artnum>496</artnum><issn>2041-1723</issn><eissn>2041-1723</eissn><abstract>Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signaling pathway to resist viral infection in cells and mice. Mechanistically, PBLD activates NF-κB signaling pathway during viral infection via blocking tripartite motif containing 21 (TRIM21)-mediated phosphorylated inhibitory kappa B kinase beta (IKKβ) degradation. Furthermore, we show Cedrelone inhibits viral replication by increasing the PBLD protein expression and subsequently activating NF-κB-mediated IFN-I response. Furthermore, the therapeutic potential of Cedrelone lies in its ability to enhance antiviral immunity in primary macrophages and to promote survival and reduce lung tissue damage in HSV-1-infected mice in a PBLD-dependent manner. Consequently, our findings provide a potential combination model that targets PBLD for Cedrelone antiviral drug therapy, potentially paving the way for the development of broad-spectrum antiviral agents.
Phenazine biosynthesis-like domain-containing protein (PBLD) and cedrelone play roles in tumor suppression. Here, authors suggest that PBLD and Cedrelone inhibit viral replication via activating the NF-κB-mediated IFN-I signaling response in cells and mice.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>39779683</pmid><doi>10.1038/s41467-024-54882-y</doi><tpages>18</tpages><orcidid>https://orcid.org/0000-0002-7438-0638</orcidid><orcidid>https://orcid.org/0009-0003-1629-1172</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2041-1723 |
ispartof | Nature communications, 2025-01, Vol.16 (1), p.496-18, Article 496 |
issn | 2041-1723 2041-1723 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_3bfbd6c408b749bfa92e6e7f71512fb9 |
source | Nature; Publicly Available Content (ProQuest); PubMed Central; Coronavirus Research Database; Springer Nature - nature.com Journals - Fully Open Access |
subjects | 13/1 13/109 13/31 13/95 14/19 38 42 45 49 59 631/250/2504/342 631/250/255/2514 631/250/262 631/326/596/2553 64 64/86 96 Animals Antiviral agents Antiviral Agents - pharmacology Antiviral drugs Biosynthesis Cell survival Chemotherapy Cyclohexanones - pharmacology Drug therapy Female HEK293 Cells Herpes Simplex - drug therapy Herpes Simplex - immunology Herpes Simplex - virology Herpesvirus 1, Human - drug effects Herpesvirus 1, Human - immunology Humanities and Social Sciences Humans I-kappa B Kinase - metabolism Immune response Immune system Infections Interferon Interferon Type I - immunology Interferon Type I - metabolism Intracellular Signaling Peptides and Proteins Kinases Macrophages Macrophages - drug effects Macrophages - immunology Macrophages - metabolism Mice Mice, Inbred C57BL Mice, Knockout multidisciplinary NF-kappa B - metabolism NF-κB protein Phenazine Phenazines - pharmacology Protein biosynthesis Proteins Replication Science Science (multidisciplinary) Signal transduction Signal Transduction - drug effects Suppressors Tumor suppression Tumors Viral infections Virus Replication - drug effects |
title | Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T23%3A54%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phenazine%20biosynthesis-like%20domain-containing%20protein%20(PBLD)%20and%20Cedrelone%20promote%20antiviral%20immune%20response%20by%20activating%20NF-%C4%B8B&rft.jtitle=Nature%20communications&rft.au=Hou,%20Peili&rft.date=2025-01-08&rft.volume=16&rft.issue=1&rft.spage=496&rft.epage=18&rft.pages=496-18&rft.artnum=496&rft.issn=2041-1723&rft.eissn=2041-1723&rft_id=info:doi/10.1038/s41467-024-54882-y&rft_dat=%3Cproquest_doaj_%3E3152797469%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-59e011013b9c143147216ce586462d0cb12de8d9d4cf1b843bdadb840bad0bf3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3152797469&rft_id=info:pmid/39779683&rfr_iscdi=true |